233 related articles for article (PubMed ID: 36768298)
1. The Role of Different Types of microRNA in the Pathogenesis of Breast and Prostate Cancer.
Sidorova EA; Zhernov YV; Antsupova MA; Khadzhieva KR; Izmailova AA; Kraskevich DA; Belova EV; Simanovsky AA; Shcherbakov DV; Zabroda NN; Mitrokhin OV
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768298
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-9 and breast cancer.
Li X; Zeng Z; Wang J; Wu Y; Chen W; Zheng L; Xi T; Wang A; Lu Y
Biomed Pharmacother; 2020 Feb; 122():109687. PubMed ID: 31918267
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs and prostate cancer.
Pang Y; Young CY; Yuan H
Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):363-9. PubMed ID: 20539944
[TBL] [Abstract][Full Text] [Related]
4. TATDN1 promotes the development and progression of breast cancer by targeting microRNA-140-3p.
Yu XY; Tian JR; Yang D; Tan HR
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5293-5300. PubMed ID: 31298381
[TBL] [Abstract][Full Text] [Related]
5. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
[TBL] [Abstract][Full Text] [Related]
6. Implications of microRNA dysregulation in the development of prostate cancer.
Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells.
Wang C; Tao W; Ni S; Chen Q; Zhao Z; Ma L; Fu Y; Jiao Z
Cancer Sci; 2015 Apr; 106(4):375-82. PubMed ID: 25645686
[TBL] [Abstract][Full Text] [Related]
9. miRNAs in breast cancer tumorigenesis (Review).
Zhang ZJ; Ma SL
Oncol Rep; 2012 Apr; 27(4):903-10. PubMed ID: 22200848
[TBL] [Abstract][Full Text] [Related]
10. microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients.
Bakkar A; Alshalalfa M; Petersen LF; Abou-Ouf H; Al-Mami A; Hegazy SA; Feng F; Alhajj R; Bijian K; Alaoui-Jamali MA; Bismar TA
Mol Biol Rep; 2016 Apr; 43(4):229-40. PubMed ID: 26907180
[TBL] [Abstract][Full Text] [Related]
11. microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements.
Schwickert A; Weghake E; Brüggemann K; Engbers A; Brinkmann BF; Kemper B; Seggewiß J; Stock C; Ebnet K; Kiesel L; Riethmüller C; Götte M
PLoS One; 2015; 10(12):e0143993. PubMed ID: 26657485
[TBL] [Abstract][Full Text] [Related]
12. Roles of microRNAs during prostatic tumorigenesis and tumor progression.
Fang YX; Gao WQ
Oncogene; 2014 Jan; 33(2):135-47. PubMed ID: 23455326
[TBL] [Abstract][Full Text] [Related]
13. The role of microRNAs in prostate cancer migration, invasion, and metastasis.
Aghdam SG; Ebrazeh M; Hemmatzadeh M; Seyfizadeh N; Shabgah AG; Azizi G; Ebrahimi N; Babaie F; Mohammadi H
J Cell Physiol; 2019 Jul; 234(7):9927-9942. PubMed ID: 30536403
[TBL] [Abstract][Full Text] [Related]
14. miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin.
Das DK; Naidoo M; Ilboudo A; Park JY; Ali T; Krampis K; Robinson BD; Osborne JR; Ogunwobi OO
Exp Cell Res; 2016 Nov; 348(2):190-200. PubMed ID: 27693493
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer and microRNAs: therapeutic impact.
Iorio MV; Casalini P; Piovan C; Braccioli L; Tagliabue E
Breast; 2011 Oct; 20 Suppl 3():S63-70. PubMed ID: 22015296
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-1236-3p inhibits proliferation and invasion of breast cancer cells by targeting ZEB1.
Liang TC; Fu WG; Zhong YS
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9988-9995. PubMed ID: 31799668
[TBL] [Abstract][Full Text] [Related]
17. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
[TBL] [Abstract][Full Text] [Related]
18. regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors.
Wilk G; Braun R
PLoS Genet; 2018 Dec; 14(12):e1007837. PubMed ID: 30557297
[TBL] [Abstract][Full Text] [Related]
19. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
Kumar B; Lupold SE
Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]